ATYR (aTyr Pharma, Inc.) Total Enterprise Value
This daily price chart for aTyr Pharma, Inc. (ATYR) reflects an Enterprise Value of -34.14. The business focuses on therapies for orphan lung pathologies, ensuring perpetual demand for its developments. However, international expansion is hindered by regulatory barriers and raw material supply issues. To mitigate risks, aTyr Pharma, Inc. (ATYR) is adapting its technologies to combat cancer, thereby diversifying its clinical pipeline.
aTyr Pharma, Inc. (ATYR) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:aTyr Pharma Inc (ATYR)
aTyr Pharma, Inc. (ATYR) is developing unique immunological drugs whose value remains independent of market cycles. The EV metric combines market capitalization and net debt to determine the total cost of acquiring the business. Investors utilize this metric to assess the actual costs of asset acquisition. The current EV value reflects the potential of the flagship candidate in late-stage testing. This chart allows for the tracking of the company's fair value.
Competitor analysis for aTyr Pharma, Inc.
ARGX - Aggregate Business Value|BNTX (BioNTech Group) - Real Price to Acquire Entire Company|ABVX: Total Enterprise Value|Total Company Value ADMA Biologics ADMA|PTGX (protagonist-inc.com) - Value Adjusted for Debt and Cash|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Total Enterprise Value Astria Therapeutics Inc ATXS|enGene Bio - Enterprise Value|RAPT Therapeutics Inc. (RAPT) - Enterprise Value|JBIO - Real Price to Acquire Entire Company|Aggregate Business Value aclaristx.com|Real Price to Acquire Entire Company KYTX (Kyverna Therapeutics, Inc.)|Total Enterprise Value TLSA|Cabaletta Bio, Inc (CABA) - Total Company Value|Value Adjusted for Debt and Cash Ventyx Biosciences, Inc VTYX|Real Price to Acquire Entire Company Theratechnologies Inc.|avalotx.com - Value Adjusted for Debt and Cash|Total Company Value Eledon Pharmaceuticals, Inc.|AGEN - Full Business Value|Enterprise Value Climb Bio, Inc. CLYM|Zura Bio Ltd (ZURA) - Value Adjusted for Debt and Cash|ADAG (Adagene Inc) - Enterprise Value|Enterprise Value IMA|Shattuck Labs, Inc. (STTK) - Total Company Value|Value Adjusted for Debt and Cash EQ (equilliumbio.com)|Connect Biopharma Holdings Limited - Total Company Value|Real Price to Acquire Entire Company Immunic Therapeutics IMUX|Atara Biotherapeutics Inc - Enterprise Value|InflaRx N.V. (IFRX) - Enterprise Value|Real Price to Acquire Entire Company X4 Pharmaceuticals, Inc. XFOR|Adicet Bio, Inc. (ACET) - Value Adjusted for Debt and Cash|CELU: Enterprise Value|Company Buyout Price INMB|Total Company Value Barinthus Biotherapeutics BRNS|Business Value kezarlifesciences.com (KZR)|SAB Biotherapeutics, Inc. - Enterprise Value|AKTX - Real Price to Acquire Entire Company|Real Price to Acquire Entire Company ENLV (Enlivex Therapeutics, Ltd.)|QTTB - Company Buyout Price|GOVX: Enterprise Value|Enterprise Value edesabiotech.com|iBio (IBIO) - Real Price to Acquire Entire Company|Aggregate Business Value Carisma Tx (CARM)|XTL Biopharmaceuticals, Ltd. - Real Price to Acquire Entire Company|Total Enterprise Value BOLT (boltbio.com)|Total Company Value HCW Biologics|Aptevo Therapeutics, Inc. - Value Adjusted for Debt and Cash|Total Company Value AIM ImmunoTech Inc.|ADTX - Full Business Value|Enterprise Value GRI Bio Corp GRI|XORTX Corp (XRTX) - Value Adjusted for Debt and Cash|HIND (Vyome Holdings Inc) - Enterprise Value|Enterprise Value REVB|Indaptus Therapeutics, Inc. (INDP) - Total Company Value|Value Adjusted for Debt and Cash SCNI (Scinai Immunotherapeutics Ltd)|CalciMedica - Total Company Value|Real Price to Acquire Entire Company Affimed NV AFMD|Allakos Therapeutics - Enterprise Value|HOOKIPA Pharma Inc. (HOOK) - Enterprise Value|Real Price to Acquire Entire Company igmbio.com IGMS|iTeos Therapeutics Inc (ITOS) - Value Adjusted for Debt and Cash|OCEA: Enterprise Value|Company Buyout Price TCBP|Total Company Value THRD (Third Harmonic Bio)